Preparation of Paclitaxel-Loaded Microspheres with Fe3O4 Nanoparticles and Study of their Target-Orientation and Sustained-Release Property

Article Preview

Abstract:

Paclitaxel-loaded microspheres with magnetic Fe3O4 nanoparticles were synthesized with albumin as carrier. The morphology was characterized by high-resolution transmission electron microscopy (HRTEM). The drug-loading rate and entrapment rate of the microspheres were researched by ultraviolet and visible spectrophotometer. The inhibition action of taxol microspheres to growth of esophagus cancer Eca109 cell were examined by MTT method. The result shows that it is regular spherical. The mean size and size distribution of microspheres are 275.6nm and 144.3nm by Zetasizer3000. The drug-loading rate is 3.013% and the entrapment rate is 35.26%. It has excellent target-orientation and sustained-release property which can prevent the growth of Eca109 cell.

You might also be interested in these eBooks

Info:

Periodical:

Advanced Materials Research (Volumes 535-537)

Pages:

521-524

Citation:

Online since:

June 2012

Export:

Price:

Permissions CCC:

Permissions PLS:

Сopyright:

© 2012 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

[1] M. Lee, S. Lim, C. Kim, Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles, Biomater.28(12)(2007) 2137-2146.

DOI: 10.1016/j.biomaterials.2007.01.014

Google Scholar

[2] W. Seow, J.Xue, Y.Yang. Targeted and intracellular delivery of paclitaxel using multi-functional polymeric micelles, Biomater.28(9)(2007)1730-1740.

DOI: 10.1016/j.biomaterials.2006.11.039

Google Scholar

[3] B.L. Lin, X.D. Shen, S., Cui, Application of nanosized Fe3O4 in anticancer drug carriers with target-orientation and sustained-release properties, Biomed.Mater. 2(2007)132-134.

DOI: 10.1088/1748-6041/2/2/011

Google Scholar

[4] S. Cui, et al., Synthesis and characterization of magnetic adriamycin HAS nanoparticle, Chin. J. Biomed. Eng. 25(1)(2006)114-116.

Google Scholar

[5] N.K. Ibrahim, et al., PhaseⅠand pharmacokinetics study of ABI-007, a cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel, Clin. Cancer Res. 8(5)(2002)1038-1044.

Google Scholar

[6] B. Damascelli, et al., A novel intraarterial chemotherapy using paclitaxel in albumin nanoparticles to treat advanced squamous cell carcinoma of the tongue: preliminary findings, Am. J. Roentgenol. 181(1)(2003)253-260.

DOI: 10.2214/ajr.181.1.1810253

Google Scholar